Lazard Asset Management
SMTI icon

Lazard Asset Management’s Sanara MedTech SMTI Stock Holding History

Lazard Asset Management’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,160
Closed -$89K – 2271
2025
Q2 		$89K Buy
3,160
+3,155
+63,100% +$94.6K ﹤0.01% 1892
2025
Q1 		$0 Sell
5
-1
-17% -$34 ﹤0.01% 2561
2024
Q4 		$0 Sell
6
-7,595
-100% -$258K ﹤0.01% 2521
2024
Q3 		$229K Buy
7,601
+2,970
+64% +$92.6K ﹤0.01% 1573
2024
Q2 		$130K Buy
4,631
+2,065
+80% +$64.8K ﹤0.01% 1676
2024
Q1 		$94K Sell
2,566
-50
-2% -$1.87K ﹤0.01% 1552
2023
Q4 		$107K Buy
2,616
+105
+4% +$3.37K ﹤0.01% 1635
2023
Q3 		$78K Buy
+2,511
New +$97.3K ﹤0.01% 1716
2022
Q4 		– Sell
-748
Closed -$22K – 2557
2022
Q3 		$22K Sell
748
-1,016
-58% -$28.4K ﹤0.01% 2076
2022
Q2 		$36K Buy
1,764
+621
+54% +$14.5K ﹤0.01% 1951
2022
Q1 		$31K Hold
1,143
– – ﹤0.01% 1955
2021
Q4 		$34K Buy
1,143
+67
+6% +$2.11K ﹤0.01% 1887
2021
Q3 		$36K Sell
1,076
-45
-4% -$1.61K ﹤0.01% 1831
2021
Q2 		$41K Buy
+1,121
New +$32.8K ﹤0.01% 1670

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Lazard Asset Management's SMTI Position: Q3 2025 in Review

Lazard Asset Management sold out of Sanara MedTech (SMTI) in Q3 2025, closing a stake of 3,160 shares — an estimated $89K sold.

Lazard Asset Management first reported a position in SMTI in Q2 2021 and held it in 14 quarters. The position peaked at $229K in Q3 2024. 58 funds tracked by Wall St. Rank hold SMTI as of Q3 2025.

  • Lazard Asset Management reported no remaining Sanara MedTech position as of Q3 2025 after selling out during the quarter.
  • Lazard Asset Management sold 3,160 Sanara MedTech shares in Q3 2025, an estimated $89K.
  • Lazard Asset Management first reported a position in Sanara MedTech in Q2 2021 and held it in 14 quarters.
  • Lazard Asset Management's Sanara MedTech position peaked at $229K in Q3 2024.
  • 58 funds tracked by Wall St. Rank held Sanara MedTech as of Q3 2025.

Based on Lazard Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.